Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS).

ABSTRACT:

Background

Acute respiratory distress syndrome (ARDS) is a critical condition that is associated with high mortality and morbidity. Aerosolized prostacyclin has been used to improve oxygenation despite the limited evidence available so far.This review was originally published in 2010 and updated in 2017.

Objectives

To assess the benefits and harms of aerosolized prostacyclin in adults and children with ARDS.

Search methods

In this update, we searched CENTRAL (2017, Issue 4); MEDLINE (OvidSP), Embase (OvidSP), ISI BIOSIS Previews, ISI Web of Science, LILACS, CINAHL (EBSCOhost), and three trials registers. We handsearched the reference lists of the latest reviews, randomized and non-randomized trials, and editorials, and cross-checked them with our search of MEDLINE. We

SUBMITTER: Afshari A 

PROVIDER: S-EPMC6483148 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature